HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease

Overview of attention for article published in Frontiers in Physiology, April 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

OXADIAZOLE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS

Application EP-3565807-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.